Quick Answer
Yes, Medicare Part B covers Supartz FX injections for knee osteoarthritis when medical necessity criteria are met. Supartz FX is typically given as a series of 3 to 5 weekly injections. Most patients pay 20% coinsurance after meeting their Part B deductible.
Medicare Part B Coverage for Supartz FX
Supartz FX is a sodium hyaluronate viscosupplement made by Smith & Nephew. It has been used for viscosupplementation for over two decades and has one of the longest track records among HA injection products. Medicare covers Supartz FX under Part B (the medical benefit) because it is administered in a physician’s office or outpatient setting.
Key coverage facts:
- Covered under Part B as a physician-administered injectable
- No prior authorization required under Original Medicare
- Subject to Local Coverage Determinations (LCDs) from your regional MAC
- Must meet medical necessity criteria documented in your medical records
- Flexible dosing: FDA-approved for 3 to 5 weekly injections per treatment course
Coverage Requirements
Medical Necessity Criteria
For Medicare to pay for Supartz FX, your medical records must show:
- Diagnosis of knee osteoarthritis with ICD-10 code M17.x
- Failure of conservative treatment for at least 3 months, including physical therapy, oral medications (NSAIDs), or activity modification
- Chart documentation showing these prior treatments did not adequately relieve your symptoms
- X-ray evidence confirming osteoarthritis (most MACs require imaging within the past 12 months)
Billing Codes
| Code | Description | 2026 Estimated Allowable |
|---|---|---|
| J7321 | Supartz FX (sodium hyaluronate), per dose | $150 - $250 per injection |
| 20610 | Arthrocentesis, large joint (knee) | $85 - $110 |
| 77002 | Fluoroscopic guidance (if used) | $75 - $95 |
Your provider bills Medicare using J-code J7321 for each Supartz FX injection. Since Supartz FX may be given as 3 to 5 injections, the code is submitted for each injection in the series.
Frequency Limits
- Medicare typically covers one treatment course (3-5 weekly injections) per knee every 6 months
- Some MACs allow repeat treatment after 6 months if the initial course provided clinical benefit
- The number of injections per course (3, 4, or 5) is at your provider’s discretion based on clinical judgment
- Bilateral knee treatment is generally covered when both knees have documented OA
Your Out-of-Pocket Costs
| Item | Amount |
|---|---|
| Part B deductible (2026) | $257/year |
| Coinsurance | 20% of Medicare-approved amount |
| Typical total patient cost | $100 - $300 per treatment course |
| With Medigap | May cover the 20% coinsurance |
Example Cost Calculation
If Medicare approves $200 per injection for a 5-injection course ($1,000 total):
- Medicare pays: $800 (80%)
- You pay: $200 (20%)
- If you have a Medigap plan: your supplement may cover some or all of that $200
Medicare Advantage Plans
If you have a Medicare Advantage (Part C) plan:
- Coverage generally follows Original Medicare guidelines
- Prior authorization may be required — check before scheduling
- Copays vary by plan and may differ from standard 20% coinsurance
- Network restrictions may apply — verify your provider is in-network
- Contact your plan’s member services to confirm coverage before your appointment
What If Medicare Denies Coverage?
If your Supartz FX claim is denied:
- Request the denial reason in writing
- Gather supporting documents including X-rays, treatment history, and a letter of medical necessity from your provider
- File a redetermination (Level 1 appeal) within 120 days
- Include clinical evidence showing why Supartz FX is medically appropriate for your condition
Many initial denials are overturned on appeal with proper supporting documentation.
Supartz FX Product Details
| Feature | Detail |
|---|---|
| Manufacturer | Smith & Nephew |
| Active ingredient | Sodium hyaluronate (purified) |
| Injection schedule | 3 to 5 injections, given 1 week apart |
| FDA-approved for | Knee osteoarthritis |
| Molecular weight | 620,000 - 1,170,000 daltons |
| Source | Avian-derived (chicken comb extract) |
| Volume per injection | 2.5 mL |
Supartz FX has been available in the U.S. since 2001 and has been used in Japan since 1987, giving it one of the longest clinical track records among viscosupplements. Its flexible dosing schedule (3 to 5 injections) allows providers to tailor treatment to each patient.
Frequently Asked Questions
How often will Medicare pay for Supartz FX?
Medicare generally covers one treatment course per knee every 6 months. A treatment course consists of 3 to 5 weekly injections. Your provider must document medical necessity and clinical benefit from prior treatment.
Do I need prior authorization for Supartz FX under Medicare?
No. Original Medicare does not require prior authorization for Supartz FX. Medicare Advantage plans may have their own prior authorization requirements, so verify with your plan before scheduling.
Is Supartz FX covered under Medicare Advantage?
Yes. Medicare Advantage plans must cover everything Original Medicare covers. However, your plan may have different cost-sharing amounts, network requirements, or prior authorization rules. Contact your plan for specifics.
What is the difference between 3 and 5 injections?
Your provider determines whether you need 3, 4, or 5 injections based on your specific situation. Some patients respond well to a shorter series, while others benefit from the full 5-injection course. Medicare covers the number of injections your provider deems medically necessary.
Does Supartz FX contain animal products?
Yes. Supartz FX is derived from chicken combs (avian source). If you have a known allergy to poultry, feathers, or eggs, tell your doctor before treatment. Non-avian alternatives like Euflexxa are available.